In vitro chemosensitivity testing of selected myeloid cells in acute myeloid leukemia

Leukemia and Lymphoma

Volumn 44, Issue 5, 2003, Pages 783-789

  Möllgård, Lars ^a   Prenkert, Malin ^b   Smolowicz, Adam ^b   Paul, Christer ^a   Tidefelt, Ulf ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myeloid leukemia; Chemosensitivity; Cytotoxicity; Drug resistance; Flow cytometry

Indexed keywords

AMSACRINE; ANTHRAQUINONE; ANTINEOPLASTIC AGENT; CD33 ANTIGEN; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE; PROPIDIUM IODIDE; TIOGUANINE; VALSPODAR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG RESPONSE; DRUG SELECTIVITY; DRUG SENSITIVITY; FEASIBILITY STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL COUNT; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEASIBILITY STUDIES; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; MYELOID CELLS;

EID: 0037402427     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000067594     Document Type: Article

References (35)

1. Bennett, J.M., Young, M.L., Andersen, J.W., Cassileth, P.A., Tallman, M.S., Paietta, E., Wiernik, P.H. and Rowe, J.M. (1997) "Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience", Cancer 80, 2205-2209.
2. Bradshaw, D.M. and Arceci, R.J. (1998) "Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance", J. Clin. Oncol. 16, 3674-3690 [Published erratum appears in J. Clin. Oncol. (1999) (17)(4), 1330].
3. McKenna, S.L. and Padua, R.A. (1997) "Multidrug resistance in leukaemia", Br. J. Haematol. 96, 659-674.
4. Gruber, A., Vitols, S., Norgren, S., Arestrom, I., Peterson, C., Bjorkholm, M., Reizenstein, P. and Luthman, H. (1992) "Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia", Br. J. Cancer 66, 266-272.
5. Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Grever, M.R., Appelbaum, F.R. and Willman, C.L. (1999) "Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study", Blood 94, 1086-1099.
6. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D. and Fiere, D. (1992) "Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis", Blood 79, 473-476.
7. Legrand, O., Simonin, G., Beauchamp-Nicoud, A., Zittoun, R. and Marie, J.P. (1999) "Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia", Blood 94, 1046-1056.
8. Wood, P., Burgess, R., MacGregor, A. and Yin, J.A. (1994) "P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival", Br. J. Haematol. 87, 509-514.
9. Guerci, A., Merlin, J.L., Missoum, N., Feldmann, L., Marchal, S., Witz, F., Rose, C. and Guerci, O. (1995) "Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry", Blood 85, 2147-2153.
10. Hamburger, A.W. and Salmon, S.E. (1977) "Primary bioassay of human tumor stem cells", Science 197, 461-463.
11. Delmer, A., Marie, J.P., Thevenin, D., Suberville, A.M. and Zittoun, R. (1993) "Treatment of relapsing and refractory adult acute myeloid leukemia according to in vitro clonogenic leukemic cell drug sensitivity", Leuk. Lymphoma 10, 67-71.
12. Cree, I.A., Pazzagli, M., Mini, E., Mazzei, T., Hunter, E.M., Sutherland, L.A., Pinzani, P., Gerli, A. and Andreotti, P.E. (1995) "Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay", Anticancer Drugs 6, 398-404.
13. Bird, M.C., Bosanquet, A.G., Forskitt, S. and Gilby, E.D. (1986) "Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies", Leuk. Res. 10, 445-449.
14. Weisenthal, L.M., Marsden, J.A., Dill, P.L. and Macaluso, C.K. (1983) "A novel dye exclusion method for testing in vitro chemosensitivity of human tumors", Cancer Res. 43, 749-757.
15. Pieters, R., Huismans, D.R., Leyva, A. and Veerman, A.J. (1989) "Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia", Br. J. Cancer 59, 217-220.
16. Larsson, R., Kristensen, J., Sandberg, C. and Nygren, P. (1992) "Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)", Int. J. Cancer 50, 177-185.
17. Rhedin, A.S., Tidefelt, U., Jonsson, K., Lundin, A. and Paul, C. (1993) "Comparison of a bioluminescence assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells", Leuk. Res. 17, 271-276.
18. Tidefelt, U., Sundman-Engberg, B., Rhedin, A.S. and Paul, C. (1989) "In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations", Eur. J. Haematol. 43, 374-384.
19. Staib, P., Lathan, B., Schinkothe, T., Wiedenmann, S., Pantke, B., Dimski, T., Voliotis, D. and Diehl, V. (1999) "Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci", Adv. Exp. Med. Biol. 457, 437-444.
20. Norgaard, J.M., Langkjer, S.T., Palshof, T., Clausen, N., Pedersen, B. and Hokland, P. (1996) "Relation of blast cell survival and proliferation to chemotherapy resistance in AML", Br. J. Haematol. 93, 888-897.
21. Klumper, E., Ossenkoppele, G.J., Pieters, R., Huismans, D.R., Loonen, A.H., Rottier, A., Westra, G. and Veerman, A.J. (1996) "In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia", Br. J. Haematol. 93, 903-910.
22. Kristensen, J., Jonsson, B., Sundstrom, C., Nygren, P. and Larsson, R. (1992) "In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia", Med. Oncol. Tumor Pharmacother. 9(1992), 65-74 [Published erratum appears in Med. Oncol. Tumor Pharmacother (1992) (9)(3), 157].
23. Mollgard, L., Tidefelt, U., Sundman-Engberg, B., Lofgren, C. and Paul, C. (2000) "In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay", Leuk. Res. 24, 445-452.
24. Staib, P., Schinkothe, T., Heinrichs, T., Siebert, T., Dimski, T., Schoch, C., Reiser, M., Voliotis, D., Lathan, B. and Diehl, V. (2000) "Primary resistant disease in adult AML is well predicted by in-vitro drug sensitivity testing", Blood 96(Suppl. 1), 824a, Abstract.
25. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1985) "Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group", Ann. Intern. Med. 103, 620-625.
26. Boyum, A. (1968) "Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents", Scand. J. Clin. Lab Investig. Suppl. 97, 31-50.
27. Sundman-Engberg, B., Tidefelt, U., Liliemark, J. and Paul, C. (1990) "Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo", Cancer Chemother Pharmacol. 25, 252-256.
28. Pavlik, E.J., Flanigan, R.C., van Nagell, Jr., J.R., Hanson, M.B., Donaldson, E.S., Keaton, K., Doss, B., Bartmas, J. and Kenady, D.E. (1985) "Esterase activity, exclusion of propidium iodide, and proliferation in tumor cells exposed to anticancer agents: phenomena relevant to chemosensitivity determinations", Cancer Investig. 3, 413-426.
29. Ashmun, R.A. and Look, A.T. (1990) "Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells", Blood 75, 462-469.
30. Campana, D., Manabe, A. and Evans, W.E. (1993) "Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs", Leukemia 7, 482-488.
31. Simmons, D. and Seed, B. (1988) "Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells", J. Immunol. 141, 2797-2800.
32. Jonsson, B. (1998) "Circumventing drug resistance. Studies exploring the expediency of a total cell kill chemoresistance assay" Thesis. Acta Universitatis Upsaliensis.
33. Norgaard, J.M., Olesen, G., Kristensen, J.S., Pedersen, B. and Hokland, P. (1999) "Leukaemia cell drug resistance and prognostic factors in AML", Eur. J. Haematol. 63, 219-224.
34. Stute, N., Kohler, T., Lehmann, L., Wetzstein, W. and Ehninger, G. (1999) "Drug resistance testing of acute myeloid leukemia in adults using the MTT assay", Adv. Exp. Med. Biol. 457, 445-452.
35. Mansson, E., Paul, A., Lofgren, C., Ullberg, K., Paul, C., Eriksson, S. and Albertioni, F. (2001) "Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy", Br. J. Haematol. 114, 557-565.